131 related articles for article (PubMed ID: 12009939)
1. Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapy.
Lindegren S; Andersson H; Jacobsson L; Bäck T; Skarnemark G; Karlsson B
Bioconjug Chem; 2002; 13(3):502-9. PubMed ID: 12009939
[TBL] [Abstract][Full Text] [Related]
2. (211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as multicarriers.
Lindegren S; Karlsson B; Jacobsson L; Andersson H; Hultborn R; Skarnemark G
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3873S-9S. PubMed ID: 14506185
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of avidin antibody pretargeting using 211At-labeled and biotinylated poly-L-lysine as effector molecule.
Frost SH; Jensen H; Lindegren S
Cancer; 2010 Feb; 116(4 Suppl):1101-10. PubMed ID: 20127953
[TBL] [Abstract][Full Text] [Related]
4. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
Dekempeneer Y; Bäck T; Aneheim E; Jensen H; Puttemans J; Xavier C; Keyaerts M; Palm S; Albertsson P; Lahoutte T; Caveliers V; Lindegren S; D'Huyvetter M
Mol Pharm; 2019 Aug; 16(8):3524-3533. PubMed ID: 31268724
[TBL] [Abstract][Full Text] [Related]
5. In vivo distribution of avidin-conjugated MX35 and (211)At-labeled, biotinylated poly-L-lysine for pretargeted intraperitoneal α-radioimmunotherapy.
Frost SH; Bäck T; Chouin N; Jensen H; Hultborn R; Jacobsson L; Lindegren S
Cancer Biother Radiopharm; 2011 Dec; 26(6):727-36. PubMed ID: 22087606
[TBL] [Abstract][Full Text] [Related]
6. Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At.
Wilbur DS; Hamlin DK; Chyan MK; Brechbiel MW
Bioconjug Chem; 2008 Jan; 19(1):158-70. PubMed ID: 18072725
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
[TBL] [Abstract][Full Text] [Related]
8. Astatine-211-labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy.
Foulon CF; Alston KL; Zalutsky MR
Nucl Med Biol; 1998 Feb; 25(2):81-8. PubMed ID: 9468020
[TBL] [Abstract][Full Text] [Related]
9. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy.
Marysael T; Bauwens M; Ni Y; Bormans G; Rozenski J; de Witte P
Invest New Drugs; 2012 Dec; 30(6):2132-40. PubMed ID: 22187204
[TBL] [Abstract][Full Text] [Related]
10. High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate.
Lindegren S; Andersson H; Bäck T; Jacobsson L; Karlsson B; Skarnemark G
Nucl Med Biol; 2001 Jan; 28(1):33-9. PubMed ID: 11182562
[TBL] [Abstract][Full Text] [Related]
11. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution.
Jeong JM; Kinuya S; Paik CH; Saga T; Sood VK; Carrasquillo JA; Neumann RD; Reynolds JC
Nucl Med Biol; 1994 Oct; 21(7):935-40. PubMed ID: 9234347
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211.
Timperanza C; Jensen H; Hansson E; Bäck T; Lindegren S; Aneheim E
EJNMMI Radiopharm Chem; 2024 May; 9(1):43. PubMed ID: 38775973
[TBL] [Abstract][Full Text] [Related]
13. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
Hoya K; Guterman LR; Miskolczi L; Hopkins LN
Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
[TBL] [Abstract][Full Text] [Related]
14. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapy.
Hainsworth J; Harrison P; Mather SJ
Bioconjug Chem; 2005; 16(6):1468-74. PubMed ID: 16287243
[TBL] [Abstract][Full Text] [Related]
16. Biotinylated iodo-polylysine for pretargeted radiation delivery.
del Rosario RB; Wahl RL
J Nucl Med; 1993 Jul; 34(7):1147-51. PubMed ID: 8315493
[TBL] [Abstract][Full Text] [Related]
17. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
[TBL] [Abstract][Full Text] [Related]
18. Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [99mTc(N)(PNP)]2+ metal fragment.
Bolzati C; Caporale A; Agostini S; Carta D; Cavazza-Ceccato M; Refosco F; Tisato F; Schievano E; Bandoli G
Nucl Med Biol; 2007 Jul; 34(5):511-22. PubMed ID: 17591551
[TBL] [Abstract][Full Text] [Related]
19. Immobilization of peroxidase on SiO2 surfaces with the help of a dendronized polymer and the avidin-biotin system.
Fornera S; Balmer TE; Zhang B; Schlüter AD; Walde P
Macromol Biosci; 2011 Aug; 11(8):1052-67. PubMed ID: 21567955
[TBL] [Abstract][Full Text] [Related]
20. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
